FDA Warning Letter Draft Pilot Covers QSR, 510(k) And Labeling Violations
This article was originally published in The Gray Sheet
Executive Summary
Written explanations by manufacturers to FDA citations for quality system inspections, premarket notification submissions (510(k)) and labeling violations could prevent the agency from issuing a warning letter under a draft pilot program outlined in the Aug. 27 Federal Register.